scispace - formally typeset
J

Jiangyang Chi

Researcher at Huazhong University of Science and Technology

Publications -  9
Citations -  553

Jiangyang Chi is an academic researcher from Huazhong University of Science and Technology. The author has contributed to research in topics: Internal medicine & Transcytosis. The author has an hindex of 6, co-authored 6 publications receiving 417 citations.

Papers
More filters
Journal ArticleDOI

TNF-α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-κB and PPAR-γ.

TL;DR: In ApoE(-/-) mice, both NF-κB and PPAR-γ inhibitors alleviated the early atherosclerotic changes promoted by TNF-α and suggest that inhibitors of either NF-σB or PPar-γ can be used to target atherosclerosis.
Journal ArticleDOI

C‐reactive protein promotes atherosclerosis by increasing LDL transcytosis across endothelial cells

TL;DR: The effect of CRP on transcytosis of LDL across endothelial cells and the underlying mechanisms are examined to explore the underlying mechanism of atherosclerosis.
Journal ArticleDOI

Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.

TL;DR: The action of SAL to reduce atherosclerotic lesion formation may at least be attributed to its effect on improving endothelial function by promoting nitric oxide production, which was associated with mitochondrial depolarization and subsequent activation of the AMPK/PI3K/Akt/eNOS pathway.
Journal ArticleDOI

Salidroside Stimulates Mitochondrial Biogenesis and Protects against H2O2-Induced Endothelial Dysfunction

TL;DR: Findings implicate that SAL could protect endothelium against H2O2-induced injury via promoting mitochondrial biogenesis and function, thus preventing the overactivation of oxidative stress-related downstream signaling pathways.